Dont' go there. I definitely do not recommend intentional infection with HSV-2 at any body site. There are risks of other complications from HSV-2 (meningitis, a serious skin rash called erythema multiforme, and others). Transmission to pregnant women and newborns can be easily prevented without such a drastic measure. Cesarean section to prevent HSV transmission to newborns is uncommon these days; even if she has or develops herpes, with proper management she can expect a vaginal delivery.
I agree with your alternate implication (last sentence) that the first thing is to determine whether or not your wife already is HSV-2 positive; as the spouse of an infected partner, there is at least a 50% likelihood she is. I suspect you are wrong about availability of proper HSV blood tests in Costa Rica, which is a medically sophisticated country, or so I understand. At a minimum, there must be providers and labs that can send specimens to Quest Diagnostics, LabCorp, or other laboratories in the US.
Good luck-- HHH, MD
I suspect your legal and ethical obligations, along with some hubris, are preventing an objective analysis of the issue. Maybe you never want to be the doctor responsible for even hinting about the potential viability or benefits of the "big toe" theory. Maybe your conclusion will turn out to be correct even after an objective analysis, but isn't it for the patient to decide? Shouldn't the patient be able to decide the cost/benefit analysis? Is there a medical paper on this issue? If not, there should be an objective FAQ on this web site.
My 2 cents.
In humble honesty, I never give advice based on a medicolegal, CYA mentality. And I reject the charge of lack of objectivity. The opposite is true, i.e. those promoting the notion of intentional nongenital HSV-2 are the ones lacking in objectivity. You are reacting to the psychological impact of genital herpes and inflated perceptions of how bad the disease is. The psychological impact is real, but 90% of that impact is in fear of the unknown. 90% of infected people come to the realization that it's mostly not so bad, and that their pre-infection, or early infection, fears were not realized. So in this analysis, I put the psychological impact aside and look at the risks and benefits of the proposed strategy and compare them with the probability and consequences of getting genital HSV-2.
In that analysis, I conclude that, in general, genital HSV-2 simply is not sufficiently serious or important to go to the trouble, and the risk of other morbidity--which although infrequent can be severe. (Your 0.05% figure--or 1 in 2000 cases--probably is randomly selected, so I don't hold you to it as your definitive belief. But the actual rate of serious outcomes is far higher than that.) In the case of nsns's original question, it assumed incorrectly that neonatal herpes cannot otherwise be easily prevented. In fact, the risk of neonatal herpes in a properly managed infected pregnant women, or in a couple in whom the male partner is infected, is very low. In that circumstance, neonatal herpes is nearly 100% preventable, even with--as apparently is important to nsns and his partner--of a vaginal vs cesarean delivery.
Are there scientific papers on this notion? Of course not. But based on my analysis of the available data, I gave my advice. Of course the patient ultimately decides; I never dictate herpes management, only give my best judgment. nsns will intentionally infect his wife's foot or not. Presumably he will factor in my opinion, otherwise he wouldn't have asked the question. That doesn't mean he will follow either my reasoning or my advice; it's up to him.
In response to Englishman's question: No, the uninfected partner will not necessarily become infected eventually. The available data suggest that about half the partners ultimately are infected--perhaps higher if the couple is unaware of the infected partner's infection, but nowhere near 100%.
HHH, MD
not produce them absent infection.
I also understand the newborn baby would test positive
via an antibody test. Of course after time the test would
become negative as the antibodies go away.
The folks here have not promoted the big toe theory. We've asked questions. This is because logically it makes sense and could save loved ones from the biggest grief - the psychological stigma (legitimate or not). There is no lack of objectivity, just questions. I agree that herpes is not a big deal for most (especially if 90% don't know they have it). But that was not until I discovered I was an asymptomatic carrier. Before then, I was paranoid and feared it like the plague.
Until the medical community changes the name "herpes," the psychological impact of having genital herpes will be real and substantial. Isn't it logical that someone would want to protect their loved one from this burden?
You say of course there are no scientific papers on this notion. Why? This corroborates my point about the legal and ethical dilemmas a doctor might face. Should nsns infect his wife's foot if they decide the risk management weighs in favor of intentional infection? Or should a doctor help them?
There should be scientific papers on this - whether on humans or animals. It sounds like a very simple animal experiment and I imagine quite a few people would volunteer for this investigation too. Not sure on the legal complications for the human volunteers.
I think the "big toe" theory needs to be studied further. Could the principle work with HPV infection? I would quite happily have recurrent outbreaks on my toe to offer better genital immunity.
I understand that there is a psychological element here. But I do value each part of my body differently. I would quite happily sacrifice my penis (!!!) for my eyes (if such a bizarre situation arises). When it comes down to it, I value the little toe on my foot the least important both cosmetically and functionally.
According to eMedicine, herpetic whitlow of the finger/toe can be caused by both HSV-1 and HSV-2.
Are patients with a HSV-2 Whitlow protected from acquiring gential HSV-2?
There must be a research paper on this. There are people out there now who could be studied and would not have to be purposely infected.
would be period between the date of infection and the
time the antibodies "built up" that you would not be.
But otherwise, I think you would have significant levels
of protection at least that's my understanding
I also agree more studies need to be done. The reason given is lack of funds, but I've often suspected it has in part something to do with the financial interest of the parties.
For example, I don't think any drug manufactor can be expected to fund a study that could adversely affect his product.
Also it appears to me the research community is closely tied with drug manufactors etc. via lecture fees, consulting fees, or clinical trial contracts which needs to be better disclosed. For example, if a person agrues in a healh care periodical for generalized HSV2 testing they should disclose any relationships they may have with the test manufactor.
But that's just my opinion.
Any recommandations Dr. I just started getting my 3rd OB in 2 months this morning and I have been on 500 my Valtrex for the last 6 months straight.
I wish I had it on my big Toe!
Nsns, I wish you the best of luck with whatever decision you choose and hope that you have a happy future with the woman you love.
But remember that most infected people develop no symptoms at all or such mild ones they don't even know they are infected; and most people with recurrent outbreaks have 3-5 episodes per year. Only a few percent (probably under 2-3%) of people with genital HSV-2 have the frequency you are experiencing. General recommendations for prevention have to be based on the usual expectations, not infrequent atypical case.
Englishman: Among HSV-2 discordant couples aware of the infection, taking care to avoid sex with symptoms, using suppressive therapy, and having sex a few times a week, the overall rate of transmisison is around 3% each year. It might be higher in with more frequent outbreaks, but probabaly still not all that high. With care, Mrs. nsns will likely remain herpes free for years. (She still should have a blood test to see if she is already infected.)
I will add that it would be unethical for any health care provider to recommend a form of therapy that is clearly experimental, without writing a research protocol and getting institutional review board approval, developing written consent forms, etc. Don't hold your breath; I doubt that research ever will be done. And I will recommend against such personal trials of intentional inoculation until/unless such research is done.
This is my last comment on this thread.
HHH, MD
"Do people with HSV-2 Whitlow ever develop genital HSV-2?"
There is no ethical debate here, just a simple questionnaire and data analysis.
If it is proved that Herpetic Whitlow HSV-2 does provide immunity to genital HSV-2 then the ethics of purposeful infection comes in to play.
As Apollo13 said the threshold question is "Does it work?". Since this has not been answered anywhere in this forum I am starting to suspect that it indeed does.
It is a shame that the medical community will not explore such possibilities as there are potentially very clear benefits:
1. Less stress and potentital guilt in relationships.
2. Discordant couples could engage in unprotected sex more often. Indeed, in Nsns case, he clearly states the number of days in a year when he can not have sex because of HSV-2.
Science is about answering the questions, however, having friends (a GP and psychologist) who have worked in the medical community, I am told that the pursuit of the truth is sometimes hindered by the profits or political goals of a pharmaceutical company.
I bet 50 quid that Valtrex will not sponsor an investigation like this!
Absolutely research is influenced by profits, politics, and other nonscientific issues. And I agree that no drug company would fund the research you suggest. But not for the reason you assume. Such research would be extraordinarily expensive, definitely not "just a simple questionnaire and data analysis". An investigator would have to recruit many people with herpetic whitlow known to be due to HSV-2 (hard to find, since the bulk of cases are due to HSV-1); select for those whose sexual behavior puts them at risk for new HSV-2 infection; then follow those people with repeated examinations, blood tests, and behavioral questionnaires, probably for several years. At typical HSV-2 acquisition rates, for scientifically valid results, such a study would require hundreds of subjects (if not thousands) at a cost of many millions of dollars. Even a preliminary, pilot trial would be a few million.
No chance; it will never happen. And it would be a low priority; genital herpes simply isn't important enough. If I were research czar and had several million dollars to spend, I could think of a hundred things of higher public health priority.
HHH, MD
It appears that most HSV-2 Whitlows are from auto-innoculation from a genital infection.
Indeed all Whitlows are supposedly from auto-innoculation which suggests that prior infection of HSV in one site does not offer protection to another body site.
It is not known if having a Whitlow first offers genital protection, but from the logic outlined earlier I would assume not.
It appears that the "Big Toe" theory has probably reached its end.
Nsns I suspect that purposely infecting your wifes foot might do nothing other than give her a sore foot a few times a year and stop her catching HSV-2 of the foot in the future (which never happens anyway). Probably best to leave her foot alone.
I now find myself asking questions about the nature of herpes itself. The blood antibodies appear to be useless in controlling infection to a new body site but do protect the same body site. This makes me think that antibodies in the blood have nothing to do with immunity. The immunity must be specific to the infected area - it must be antibodies in a non-fluid tissue. I never did microbiology and am now stumped. Anyone else got any idea?
Auto innoculation most often occurs during initial infection before the body has a chance to build up anti-bodies. Once the
infection is established , transferring it to another part of the body is unlikely. Think about it. If that weren't true,
people would have HSV1 or HSV2 infections routinely all over
their bodies from auto innoculating themselves over time.
I saw the webmd stuff, but Herpes Whitlow is common amoung
medical personnel who carelessly touch a herpes sore on an
infected patient.
Those guys may be right, I don't know (seen info that might contradict their conclusions), but they said most not all were
autoinnoculations from gentital infections.
But if you get Herpes Whitlow from HSV2 and that was the source
site, after the antibodies built up you would have substantial immunity to subsequent HSV2 infections on other parts of the body.
Great discussion
Maybe Dr. HHH will comment.
1. You are most likely to touch a HSV sore with your finger (obviously).
2. The skin around the finger nails commonly has trauma (just looking at my fingers now, I can be stratches and abraded skin).
It is less likely that you would autoinnoculate the rest of your body because generally it is free from minor trauma. Intact skin is generall very protective against nearly all infections (that is one of its main functions).
Also people are advised to not touch there eye if they have herpes sores because of auto-innoculation of the eye.
The existence of auto-innoculation provides very good evidence that the "Big toe" theory would not work. I wonder why the doc didn't use these examples to dispel the theory ages ago?
- Now I am thinking there is something in it again!!!!!
What if you finger a woman who has HSV-2, I guess you could get a Whitlow, so they are potentially an STD?
I should retrain in the field of medicine, I find it fascinating.
Just one more thing if possible? I am currently on 500 mg of Valtrex and my friend told me that alott of doctors don't even mess around with prescribing that dose to people who have more then 3 or 4 Ob's a year, they just put them on the 1000mg because the 500 is usually not enougph.
The problem is that the montly cost of 1000mg Valtrex daily is $300 and living in Costa Rica you would think it would be less but it's not at all!
I want to know if I can take acyclovir because as you know it's a 10th of the price and I don't have a problem taking something a few times a day since it ends up being the same once it is in your system I figure why not?
I just don't know what the equal dose would be due to the diffrence of bioavailibity.
1000mg Valtrex = ? acyclovir split into ? doses.
Once again thanks for all that you do!
Doc, Englishman's flip flop is further evidence of our objectivity.